Dermapharm Holding SE clinical trials
Part of Themis Beteiligungs-Aktiengesellschaft, which holds 81.5% as of 2025-12-31. Source
The registry lists 27 studies whose lead sponsor is Dermapharm Holding SE or one of 3 companies grouped under it. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 17, 2025.
Our grouping of 3 registry names, not the registry’s. See them and correct one ↓
- 27studies on the registry
- 2open to participants now
Get an email when these change. Save the Dermapharm Holding SE studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
What it is testing
The drugs Dermapharm Holding SE’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Bee Venoms1 in phase 30 open · 1
- soy isoflavones1 in phase 30 open · 1
All 27 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 507
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 11 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Dermapharm Holding SE.
- Allergopharma GmbH & Co. KG23 studies →Acquired — became part of Dermapharm Holding SE, Mar 31, 2020 · source ↗
Something wrong?
- Laboratoires Arkopharma3 studies →Acquired — became part of Dermapharm Holding SE, Jan 5, 2023 · source ↗
Something wrong?
- Trommsdorff GmbH & Co. KG1 study →Acquired — became part of Dermapharm Holding SE, Jan 23, 2018 · source ↗
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 27 of 27.
- Study To Evaluate The Efficacy And Safety Of A Nutritional Supplement Based On Bergamot, Artichoke And Other Ingredients For Reducing Cholesterol Levels In Patients With Hypercholesterolemia (Metachol+)RecruitingNCT07178769Not applicable
Sponsor listed in the registry: Laboratoires Arkopharma · First submitted after Laboratoires Arkopharma became part of Dermapharm Holding SE
- Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust MitesNot yet recruitingNCT07096440
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted after Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Management of Anxiety in Intensive Care Unit Including OlfactotherapyCompletedNCT04210635
Sponsor listed in the registry: Laboratoires Arkopharma · First submitted before Laboratoires Arkopharma became part of Dermapharm Holding SE
- Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical TrialsTerminatedNCT02297490Phase 2
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Dietary Supplement on Symptom Awareness and Heart Rhythm in Patients With Cardiac ArrhythmiaCompletedNCT02652338Phase 3
Sponsor listed in the registry: Trommsdorff GmbH & Co. KG · First submitted before Trommsdorff GmbH & Co. KG became part of Dermapharm Holding SE
- Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in ChildrenCompletedNCT00841256Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial AsthmaCompletedNCT00263640Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled AsthmaCompletedNCT01353755Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen AllergensCompletedNCT00263627Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic RhinoconjunctivitisCompletedNCT00263601Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen MixtureCompletedNCT00264459Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal RhinoconjunctivitisCompletedNCT01490411Phase 2
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled AsthmaCompletedNCT00671268Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Efficacy and Safety From a High-dosed Sublingual Grass Pollen PreparationCompletedNCT00623701Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic DerivativeCompletedNCT00841516Phase 2
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) AllergensCompletedNCT00666341Phase 2
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Efficacy and Safety From a Recombinant Folding Variant of Bet v 1CompletedNCT00554983Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.CompletedNCT00665483Phase 4
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic RhinoconjunctivitisCompletedNCT00309062Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Efficacy and Safety of a Purified Standardised Wasp Venom PreparationCompletedNCT00263926Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Open Label Safety Study of a Birch Pollen Allergen ExtractCompletedNCT00818181Phase 2
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic RhinoconjunctivitisCompletedNCT00309036Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FVCompletedNCT00266526Phase 2
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Efficacy and Safety of a Purified Standardised Bee Venom PreparationCompletedNCT00263952Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Multicenter Trial of Immunotherapy With House Dust Mite AllergoidCompletedNCT00540631Phase 3
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic RhinoconjunctivitisCompletedNCT00263549Phase 4
Sponsor listed in the registry: Allergopharma GmbH & Co. KG · First submitted before Allergopharma GmbH & Co. KG became part of Dermapharm Holding SE
- Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal WomenStatus unknownNCT00235924Phase 3
Sponsor listed in the registry: Laboratoires Arkopharma · First submitted before Laboratoires Arkopharma became part of Dermapharm Holding SE